Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision indicator was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 was implemented, replacing the previous v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a new site revision label Revision: v3.4.2, and removed the government funding status notice and the older Revision: v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedNotice about a lapse in government funding and current operating status added at the top with guidance to opm.gov; page revision updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary feature added; capitalization updated for 'Last Update Submitted that Met QC Criteria'; and new labels 'No FEAR Act Data' and 'Revision: v3.4.0' appear on the page. These are minor UI/label and versioning changes that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. This appears to be a minor documentation/version update with no apparent impact on study details or user actions.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.